The viability of the primary and established glioma cells was decreased following TIMM44 silencing (Figure 3I), which also exerted anti-proliferative activity (Figure 3J) and hindered in vitro migration (Figure 3K) of the glioma cells. The gene discussed is TIMM44; the disease is central nervous system cancer.